{"id":14999,"name":"Boehringer Ingelheim Venture Fund","slug":"boehringer-ingelheim-venture-fund","website":"https://www.boehringer-ingelheim.com/","hqGeo":null,"stageFocus":["Seed","Series A"],"sectorTags":["Other","Healthcare","AI / ML"],"excludedSectors":[],"checkSizeMin":null,"checkSizeMax":null,"thesisSummary":"Backed digital pathology company Aignostics, indicating openness to computational pathology and translational diagnostics with pharmaceutical applications.","thesisNarrative":null,"logoUrl":null,"aumUsd":null,"submissionUrl":null,"linkedinUrl":null,"twitterHandle":null,"portfolio":[{"companyName":"Obulytix","companyUrl":null,"stage":"early-stage / seed","sector":"anti-infectives / AMR","investmentYear":null,"description":"Develops engineered-enzyme precision antimicrobials for antimicrobial-resistant bacterial infections","amountUsd":null,"relevanceNote":null,"fundName":"Boehringer Ingelheim Venture Fund"},{"companyName":"Glox Therapeutics","companyUrl":null,"stage":"early-stage","sector":"anti-infectives / AMR","investmentYear":null,"description":"Develops precision antibiotic therapies based on bacteriocins to target AMR bacteria","amountUsd":null,"relevanceNote":null,"fundName":"Boehringer Ingelheim Venture Fund"},{"companyName":"QUANTRO Therapeutics","companyUrl":null,"stage":"seed","sector":"oncology / therapeutics","investmentYear":null,"description":"Therapeutics company with a seed financing round that explicitly included Boehringer Ingelheim Venture Fund","amountUsd":null,"relevanceNote":null,"fundName":"Boehringer Ingelheim Venture Fund"},{"companyName":"Abexxa Biologics","companyUrl":null,"stage":"research stage","sector":"oncology / biopharma","investmentYear":null,"description":"Research-stage biopharmaceutical company developing antibody-based cancer therapies","amountUsd":null,"relevanceNote":null,"fundName":"Boehringer Ingelheim Venture Fund"},{"companyName":"Okairos AG","companyUrl":null,"stage":"clinical stage","sector":"vaccines / infectious disease","investmentYear":null,"description":"Clinical-stage vaccine company working on malaria and hepatitis C programs","amountUsd":null,"relevanceNote":null,"fundName":"Boehringer Ingelheim Venture Fund"},{"companyName":"ProTgen","companyUrl":null,"stage":"not specified on the portfolio page","sector":"cell therapy / immunology","investmentYear":null,"description":"Develops an in vitro platform to generate progenitor T cells from hematopoietic stem cells","amountUsd":null,"relevanceNote":null,"fundName":"Boehringer Ingelheim Venture Fund"},{"companyName":"Smartbax GmbH","companyUrl":null,"stage":"not specified on the portfolio page","sector":"anti-infectives / AMR","investmentYear":null,"description":"Develops novel anti-bacterial modes of action to overcome resistance and induce bacterial self-destruction","amountUsd":null,"relevanceNote":null,"fundName":"Boehringer Ingelheim Venture Fund"}],"partnerCount":9,"partners":[{"id":48386,"name":"Christian Thomsen","title":"Global External Research Director","seniority":null,"focusTags":[],"linkedinUrl":"https://www.linkedin.com/in/christian-thomsen-21a5008","twitterHandle":null,"blogUrl":null,"thesisSummary":null,"whyThisPartner":null,"recentPosts":[]},{"id":48387,"name":"Dustin Ensign","title":"Director of Medical Education","seniority":null,"focusTags":[],"linkedinUrl":"https://www.linkedin.com/in/ensign","twitterHandle":null,"blogUrl":null,"thesisSummary":null,"whyThisPartner":null,"recentPosts":[]},{"id":48388,"name":"Alexander Haydl","title":"Chief AI Officer","seniority":null,"focusTags":[],"linkedinUrl":"https://www.linkedin.com/in/alexander-haydl-09a5b1124","twitterHandle":null,"blogUrl":null,"thesisSummary":null,"whyThisPartner":null,"recentPosts":[]},{"id":48389,"name":"Petra Kienle","title":"Director of Communications","seniority":null,"focusTags":[],"linkedinUrl":"https://www.linkedin.com/in/petra-kienle-31abb313","twitterHandle":null,"blogUrl":null,"thesisSummary":null,"whyThisPartner":null,"recentPosts":[]},{"id":48394,"name":"Sara Lapomarda","title":"Senior Director, Strategic Accounts","seniority":null,"focusTags":[],"linkedinUrl":"https://www.linkedin.com/in/sara-lapomarda-4b5a196","twitterHandle":null,"blogUrl":null,"thesisSummary":null,"whyThisPartner":null,"recentPosts":[]},{"id":48390,"name":"Villum Wittrup-Jensen","title":"Executive Director","seniority":null,"focusTags":[],"linkedinUrl":"https://www.linkedin.com/in/dr-villum-wittrup-jensen-b58a26182","twitterHandle":null,"blogUrl":null,"thesisSummary":null,"whyThisPartner":null,"recentPosts":[]},{"id":48391,"name":"Annegret Klocker","title":"Head of Chemical Production","seniority":null,"focusTags":[],"linkedinUrl":"https://www.linkedin.com/in/annegret-klocker-277053172","twitterHandle":null,"blogUrl":null,"thesisSummary":null,"whyThisPartner":null,"recentPosts":[]},{"id":48392,"name":"Lara Crissey","title":"Director of Patient Advocacy","seniority":null,"focusTags":[],"linkedinUrl":"https://www.linkedin.com/in/laracrissey","twitterHandle":null,"blogUrl":null,"thesisSummary":null,"whyThisPartner":null,"recentPosts":[]},{"id":48393,"name":"Amador Guerrero","title":"Regional Communications Director","seniority":null,"focusTags":[],"linkedinUrl":"https://www.linkedin.com/in/amadorguerrero","twitterHandle":null,"blogUrl":null,"thesisSummary":null,"whyThisPartner":null,"recentPosts":[]}],"funds":[],"activity":{"lastInvestmentYear":null,"investmentsLast12Months":0},"investorType":"vc","preferredApproach":"warm intro preferred","prefersFounderType":null,"oneClickPitchEnabled":false,"relatedFirms":[{"id":13023,"name":"Volition Capital Fund","slug":"volition-capital-fund","logoUrl":null,"website":"https://www.volitioncapital.com/","stageFocus":["Pre-Seed"],"sectorTags":["SaaS","AI / ML","Developer Tools","Other","Security"],"hqGeo":"Boston, MA"},{"id":7722,"name":"Sheesha Finance","slug":"sheesha-finance","logoUrl":null,"website":"https://sheeshafinance.gitbook.io/","stageFocus":[],"sectorTags":["AI / ML","Developer Tools","Fintech"],"hqGeo":null},{"id":13762,"name":"NeuroNet Ventures","slug":"neuronet-ventures","logoUrl":null,"website":"https://neuronetgpo.com/","stageFocus":["Seed"],"sectorTags":["AI / ML","Other"],"hqGeo":"Chicago, IL"},{"id":12955,"name":"Jovono","slug":"jovono","logoUrl":null,"website":"https://jovono.com","stageFocus":["Seed","Series A"],"sectorTags":["Other","Climate / Energy","Fintech","Consumer","SaaS","Healthcare"],"hqGeo":"Los Angeles, CA"},{"id":10388,"name":"Africa Tech Ventures","slug":"africa-tech-ventures","logoUrl":null,"website":null,"stageFocus":["Pre-Seed","Seed"],"sectorTags":["Other","AI / ML","Food / AgTech","Consumer","Fintech","EdTech"],"hqGeo":"Nairobi, Kenya"},{"id":10277,"name":"Structural Capital Ventures","slug":"structural-capital-ventures","logoUrl":null,"website":"https://structuralcapital.com/","stageFocus":["Pre-Seed","Seed"],"sectorTags":["AI / ML","Other","Developer Tools","SaaS"],"hqGeo":"Austin, TX"}],"featuredIn":[{"slug":"seed","displayName":"Seed Investors","pageType":"stage"},{"slug":"ai","displayName":"AI & ML Investors","pageType":"industry"},{"slug":"series-a","displayName":"Series A Investors","pageType":"stage"},{"slug":"healthcare","displayName":"Healthcare Investors","pageType":"industry"}],"fundraisingResources":[{"slug":"find-right-pre-seed-investors-b2b-saas","title":"How to Find the Right Pre-Seed Investors for Your B2B SaaS Startup"},{"slug":"Finding-Investors-For-Startup-In-2026","title":"How to Find Investors for Your Startup in 2026 (Without Cold-Searching Databases)"},{"slug":"how-vcs-help-portfolio-raise-follow-on","title":"How VCs Can Actually Help Their Portfolio Companies Raise Follow-On"}],"overviewNarrative":null,"portfolioNarrative":null,"seoTitle":null,"seoDescription":null,"lastVerifiedAt":"2026-10-08T14:07:54.491Z"}